Surreal illustration of menstrual pain and ovarian cancer awareness

Period Pain and Ovarian Cancer: Is There a Link?

"A comprehensive study explores the potential connection between menstrual pain and epithelial ovarian cancer risk, offering new insights for women's health."


Ovarian cancer remains a significant health challenge for women, ranking as the fifth leading cause of cancer-related deaths in the U.S. Early detection is crucial, but less than 15% of cases are diagnosed before the cancer has spread. This makes understanding potential risk factors a critical area of research.

One area of increasing interest is the role of inflammation in ovarian cancer development. Conditions like endometriosis and pelvic inflammatory disease, which are characterized by inflammation, have been linked to increased ovarian cancer risk. Conversely, factors that reduce inflammation, such as tubal ligation and regular use of non-steroidal anti-inflammatory drugs (NSAIDs), have been associated with a decreased risk.

Menstrual pain, also known as dysmenorrhea, is a common gynecological condition often associated with heightened inflammation. While some studies have explored a possible connection between menstrual pain and ovarian cancer, the results have been inconsistent. Many of these studies were limited by small sample sizes and inadequate consideration of other potential risk factors. A new, large-scale study seeks to provide more definitive answers.

AI Search Multiple angles on this topic

Current Evidence

The relationship between period pain and ovarian cancer is not established by the information available here. Period pain is common and can have many causes, while ovarian cancer may initially cause no noticeable symptoms. Persistent, severe, or changing symptoms should be discussed with a healthcare professional.

Clinical Evaluation

Assessment of pelvic or menstrual symptoms generally depends on a healthcare professional reviewing the symptoms and deciding whether further evaluation is appropriate. No single symptom can reliably establish the cause of pelvic pain. Because early ovarian cancer may lack noticeable symptoms, symptom-based reassurance alone may have limitations.

Changing Understanding

Understanding of ovarian cancer has developed alongside broader knowledge of the reproductive system and pelvic disease. The available material does not identify specific historical milestones or discoveries linking period pain directly to ovarian cancer. Any historical account of that relationship should therefore be treated cautiously.

Does Severe Period Pain Increase Ovarian Cancer Risk?

Surreal illustration of menstrual pain and ovarian cancer awareness

A recent study by the Ovarian Cancer Association Consortium (OCAC) investigated the relationship between menstrual pain and ovarian cancer risk. The study pooled data from nine different studies, including over 10,592 cases of ovarian cancer and 13,320 control participants. This large sample size allowed researchers to examine the association with greater statistical power and to explore potential differences based on the specific type of ovarian cancer.

The study distinguished between two ways of assessing menstrual pain: direct questions and indirect questions. Direct questions specifically asked participants about their experience of severe or significant menstrual pain. Indirect questions used the use of medications, including NSAIDs, oral contraceptives, as a proxy for menstrual pain.

  • Direct questioning: Involved directly asking study participants if they experienced severe menstrual pain.
  • Indirect questioning: Used medication use as an indicator. If women reported taking pain relievers, hormones, or other medications for menstrual pain, they were classified as experiencing severe pain.
AI Search Multiple angles on this topic

What Current Reviews Show

The National Cancer Institute identifies ovarian epithelial cancer as the most common type of ovarian cancer and notes that cancer can also form at the end of the fallopian tube near the ovary or in the peritoneum before spreading to the ovary. Mayo Clinic reports that ovarian cancer may not cause noticeable symptoms when it first develops and that treatment usually involves surgery and chemotherapy. A Wikipedia overview reports that the typical age of diagnosis is 63 and that ovarian cancer is the second-most common gynecologic cancer in the United States, while also noting that global deaths increased between 1990 and 2017 by 84.2%.

Alternative Causes of Symptoms

Mayo Clinic reports that ovarian cysts are common and that most cause little or no discomfort. It also states that most cysts are harmless and go away without treatment within a few months. However, a cyst can sometimes twist or rupture, causing serious symptoms, so pelvic pain should not automatically be attributed to ovarian cancer or dismissed as routine period pain.

Interpreting Similar Symptoms

Period pain and ovarian cancer can involve symptoms in the same general pelvic region, but the available material does not establish that they have the same cause. Some pelvic symptoms may reflect common, noncancerous conditions, while ovarian cancer can initially produce no noticeable symptoms. Comparing symptoms alone is therefore unlikely to provide a definitive distinction.

The OCAC study found that, overall, women who reported severe menstrual pain based on direct questioning had a slightly elevated risk of ovarian cancer (OR = 1.07, 95% CI: 1.01-1.13). This small but statistically significant increase suggests a potential link. However, when menstrual pain was assessed using indirect questions (medication use), no association with ovarian cancer risk was observed (OR = 0.98, 95% CI: 0.89-1.07).

What Does This Mean for Women's Health?

The OCAC study provides valuable insights into the complex relationship between menstrual pain and ovarian cancer risk. The findings suggest a small but significant association between severe menstrual pain and an increased risk of ovarian cancer, particularly for clear cell and serous borderline subtypes. While recall bias and undiagnosed endometriosis could play a role, the study highlights the importance of continued research in this area.

AI Search Multiple angles on this topic

Balanced Interpretation

The available information does not support treating ordinary period pain as proof of ovarian cancer. At the same time, symptoms that are persistent, severe, or different from a person's usual pattern warrant professional assessment. A clinician is better placed to interpret symptoms in context than symptom comparison alone.

Future Directions

Further research may clarify how ovarian cancer presents across different patients and how it can be distinguished from common pelvic conditions. The supplied material does not identify a specific emerging test, treatment, or research milestone. Future progress will depend on evidence that improves earlier recognition without overstating the meaning of common symptoms.

Challenges in Recognition

A major challenge is that pelvic symptoms can have multiple explanations, including common noncancerous conditions. Ovarian cancer may also begin without noticeable symptoms, which can complicate recognition. These uncertainties make careful clinical evaluation important when symptoms persist or change.

Patient Experience

People experiencing pelvic or menstrual pain may understandably worry about ovarian cancer. The available information does not show that period pain alone identifies ovarian cancer, but it also does not justify ignoring concerning changes. Discussing ongoing or unusual symptoms with a healthcare professional can help address uncertainty and guide appropriate evaluation.

What a pooled case-control study can show

Observational study (level 4 of 8)

The study combined case-control studies and compared ovarian cancer risk in relation to reported severe menstrual pain. This design can identify an association, but it cannot establish that pain causes cancer or determine the direction of cause and effect.[1]

What the findings add to the picture

Taken together, the findings point to a modest association when severe pain was directly reported, while the indirect assessment did not show an association. The evidence therefore depends on how pain was assessed, rather than supporting a single consistent result across both approaches.[1]

The subtype estimates suggest the overall result may not describe every tumor subtype equally, but the paper notes that subtype differences were not adequately evaluated because statistical power was limited.[1]

Limits in measuring pain and interpreting risk

  • Participants’ reports of past pain may be affected by recall bias.[1]

How severe menstrual pain was assessed in the pooled analysis

Study designObservational study[1]
PopulationWomen reporting severe menstrual pain[1]
SettingLarge international pooled analysis of case-control studies[1]
ComparisonWomen without severe menstrual pain[1]
Main outcomeOvarian cancer risk[1]
Confidence interval95% CI: 1.01-1.13[1]
Times cited11[1]

Questions left by the findings

  • Would prospective studies with detailed endometriosis information find a similar association between severe menstrual pain and ovarian cancer?[1]
  • With studies that have greater statistical power, would the apparent variation by histologic subtype persist?[1]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1002/ijc.31010, Alternate LINK

Title: Menstrual Pain And Risk Of Epithelial Ovarian Cancer: Results From The Ovarian Cancer Association Consortium

Subject: Cancer Research

Journal: International Journal of Cancer

Publisher: Wiley

Authors: Ana Babic, Holly R. Harris, Allison F. Vitonis, Linda J. Titus, Susan J. Jordan, Penelope M. Webb, Harvey A. Risch, Mary Anne Rossing, Jennifer A. Doherty, Kristine Wicklund, Marc T. Goodman, Francesmary Modugno, Kirsten B. Moysich, Roberta B. Ness, Susanne K. Kjaer, Joellen Schildkraut, Andrew Berchuck, Celeste L. Pearce, Anna H. Wu, Daniel W. Cramer, Kathryn L. Terry

Published: 2017-09-21

Everything You Need To Know

1

Is there a definitive link between period pain and ovarian cancer according to the latest research?

The OCAC study indicates a small but statistically significant association between severe menstrual pain reported through direct questioning and a slightly elevated risk of ovarian cancer. However, this link was not observed when menstrual pain was assessed indirectly through medication use. This suggests that the relationship is complex and requires further investigation, especially considering potential factors like recall bias and undiagnosed endometriosis.

2

What specific types of ovarian cancer showed a potential link to severe menstrual pain in the Ovarian Cancer Association Consortium (OCAC) study?

The OCAC study indicated a potential association between severe menstrual pain and an increased risk of specific subtypes of ovarian cancer, particularly clear cell and serous borderline tumors. This suggests that the relationship between menstrual pain and ovarian cancer risk may vary depending on the specific histological type of the cancer.

3

How did the Ovarian Cancer Association Consortium (OCAC) study differentiate between assessing menstrual pain, and why is this distinction important?

The OCAC study differentiated between assessing menstrual pain using direct questions and indirect questions. Direct questions involved asking participants directly about their experience of severe menstrual pain. Indirect questions used medication use, such as NSAIDs or oral contraceptives, as a proxy for menstrual pain. This distinction is important because the study found a statistically significant association between ovarian cancer and severe menstrual pain only when assessed through direct questioning, not through medication use. This discrepancy suggests potential biases or confounding factors related to medication use.

4

What role does inflammation play in the potential connection between menstrual pain and ovarian cancer risk?

Inflammation is believed to play a role in ovarian cancer development. Conditions characterized by inflammation, such as endometriosis and pelvic inflammatory disease, have been linked to increased ovarian cancer risk. Menstrual pain, also known as dysmenorrhea, is often associated with heightened inflammation, which is why researchers are exploring a potential connection between menstrual pain and ovarian cancer. However, it's also noted that factors reducing inflammation, like tubal ligation and NSAID use, have been associated with decreased ovarian cancer risk, adding complexity to understanding the precise relationship.

5

What are the limitations of previous studies that have explored the link between menstrual pain and ovarian cancer, and how did the Ovarian Cancer Association Consortium (OCAC) study address these limitations?

Previous studies exploring the link between menstrual pain and ovarian cancer were often limited by small sample sizes and inadequate consideration of other potential risk factors. The OCAC study addressed these limitations by pooling data from nine different studies, resulting in a large sample size of over 10,592 cases of ovarian cancer and 13,320 control participants. This large sample size allowed researchers to examine the association with greater statistical power and to explore potential differences based on the specific type of ovarian cancer. The study also differentiated between direct and indirect questioning to assess menstrual pain, providing a more nuanced understanding of the potential relationship.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.